CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 

Candel Therapeutics Inc 's Working Capital Ratio

CADL's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CADL Working Capital Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter



Y / Y Current Liabilities Change - - - - -
Y / Y Current Assets Change - - - - -
Working Capital Ratio MRQ 20.68 5.44 - - -
Overall Ranking # 382 # 1356 # 1 # #
Seq. Current Liabilities Change -2.16 % - - - -
Seq. Current Assets Change 272.35 % - - - -



Working Capital Ratio third quarter 2021 Comment
Candel Therapeutics Inc 's Current Assets grew by 272.35 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Candel Therapeutics Inc 's Working Capital Ratio to 20.68, Working Capital Ratio remained below Candel Therapeutics Inc average.

Within Biotechnology & Pharmaceuticals industry 28 other companies have achieved higher Working Capital Ratio than Candel Therapeutics Inc in third quarter 2021. While Working Capital Ratio total ranking has improved so far to 382, from total ranking in previous quarter at 1356.

Explain Working Capital Ratio
Where is CADL most successful ?
Working Capital Ratio CADL on the trailing twelve month basis
Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 119
Overall Market # 382


Working Capital Ratio Statistics
High Average Low
20.68 13.06 5.44
(Sep 30 2021)   (Jun 30 2021)




Financial Statements
Candel Therapeutics Inc 's Current Liabilities $ 4 Millions Visit CADL's Balance sheet
Candel Therapeutics Inc 's Current Assets $ 91 Millions Visit CADL's Balance sheet
Source of CADL's Sales Visit CADL's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Working Capital RatioSep 30 2021 MRQ Current AssetsSep 30 2021 MRQ Current Liabilities
Talaris Therapeutics Inc   51.83 $ 258.227  Millions$ 4.982  Millions
Infinity Pharmaceuticals Inc   50.93 $ 91.926  Millions$ 1.805  Millions
Passage Bio inc   40.82 $ 366.468  Millions$ 8.978  Millions
Nanovibronix Inc  36.82 $ 9.425  Millions$ 0.256  Millions
Icosavax Inc   36.67 $ 300.276  Millions$ 8.188  Millions
Protara Therapeutics Inc   33.60 $ 95.695  Millions$ 2.848  Millions
Rubius Therapeutics inc   31.85 $ 270.468  Millions$ 8.492  Millions
Cardiff Oncology inc   30.97 $ 137.769  Millions$ 4.448  Millions
Monte Rosa Therapeutics Inc   29.08 $ 370.519  Millions$ 12.743  Millions
Vor Biopharma Inc   28.78 $ 232.072  Millions$ 8.063  Millions
In8bio Inc   28.64 $ 43.877  Millions$ 1.532  Millions
Salarius Pharmaceuticals inc   27.30 $ 35.184  Millions$ 1.289  Millions
Lixte Biotechnology Holdings Inc   27.18 $ 6.307  Millions$ 0.232  Millions
Replimune Group Inc   26.71 $ 444.384  Millions$ 16.636  Millions
Crispr Therapeutics Ag  26.18 $ 2,518.935  Millions$ 96.206  Millions
Athira Pharma Inc   25.46 $ 238.992  Millions$ 9.386  Millions
Renovacor Inc   23.86 $ 87.956  Millions$ 3.686  Millions
Assembly Biosciences inc   23.28 $ 188.219  Millions$ 8.085  Millions
Relay Therapeutics Inc   22.42 $ 639.259  Millions$ 28.517  Millions
Kymera Therapeutics Inc   22.08 $ 543.731  Millions$ 24.627  Millions
Protokinetix Incorporated  20.91 $ 0.146  Millions$ 0.007  Millions
Atyr Pharma Inc   20.89 $ 121.572  Millions$ 5.820  Millions
Tenaya Therapeutics Inc   20.80 $ 284.822  Millions$ 13.692  Millions
Candel Therapeutics Inc   20.68 $ 90.950  Millions$ 4.397  Millions
Organovo Holdings Inc   20.48 $ 34.303  Millions$ 1.675  Millions
Ginkgo Bioworks Holdings Inc   20.05 $ 1,810.569  Millions$ 90.305  Millions
Immunovant Inc   19.86 $ 563.792  Millions$ 28.383  Millions
Bionano Genomics Inc   19.78 $ 342.047  Millions$ 17.291  Millions
Solid Biosciences Inc   19.54 $ 238.810  Millions$ 12.224  Millions
Denali Therapeutics Inc   19.46 $ 1,055.509  Millions$ 54.251  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BTNB's Profile

Stock Price

BTNB's Financials

Business Description

Fundamentals

Charts & Quotes

BTNB's News

Suppliers

BTNB's Competitors

Customers & Markets

Economic Indicators

BTNB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071